Supreme Court backs generics in Novartis drug patent ruling

PUBLISHED ON: April 1, 2013 | Duration: 2 min, 23 sec

  
loading..
India's Supreme Court rejected Monday a patent bid by Swiss drug giant Novartis in a landmark ruling that activists say will protect access to cheap generic drugs and save lives in developing nations. Novartis fought a seven-year legal battle to gain patent protection for an updated version of its blockbuster cancer drug Glivec, arguing that the compound was a significant improvement because it is more easily absorbed by the body.
ALSO WATCH
प्राइम टाइम : कोरोना का टीका लगवाने से झिझक रहे हैं कैंसर मरीज

Just Added Videos

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com